Tag: bird flu

Healthy Man Dies of Toxic Shock After Taking Moderna’s New Pandemic Bird Flu mRNA-1018 Vaccine: Journal ‘Clinical Infectious Diseases’

A healthy 74-year-old man died from toxic shock syndrome during Moderna’s Phase 1/2 clinical trial of its experimental mRNA-1018 pandemic influenza vaccine, according to a study published in April in Clinical Infectious Diseases by scientists from Moderna and collaborating institutions.

The Moderna and collaborating scientists claim the death was unrelated to the Moderna shot, but without explaining how that determination was made.

The findings come as Moderna advances its mRNA-1018 pandemic bird flu vaccine with up to $54.3 million in support from the Bill Gates-backed Coalition for Epidemic Preparedness Innovations (CEPI), after the U.S. Department of Health and Human Services terminated its previous funding for the program.

A January 2023 Nature Reviews Drug Discovery paper co-authored by Moderna scientists bluntly admits that avoiding “unacceptable toxicity” in mRNA vaccines remains a major challenge, warning that “lipid nanoparticle structural components, production methods, route of administration and proteins produced from complexed mRNAs all present toxicity concerns” and that the way these vaccines spread through the body can cause harm due to “cell tropism and tissue distribution… and their possible reactogenicity.”

Moderna submitted data in November 2017 proving their mRNA vaccine lipid nanoparticles (LNPs) accumulate in mammalian liver, spleen, plasma (blood), kidneys, heart, and lungs.

Toxic shock syndrome is typically attributed to toxins produced by certain bacterial infections, but the paper provides too little clinical information to independently assess whether another mechanism, like LNPs or vaccine-induced immune system damage, may have contributed to the participant’s death.

Keep reading

CFIA still restricting ostrich farmers seven months after destroying healthy flock

Just days after supporters gathered at Universal Ostrich Farms to help clean up the aftermath of the Canadian Food Inspection Agency’s controversial $7-million ostrich cull, the family says it is once again facing government overreach.

Despite the agency’s controversial destruction of the avian flu-recovered flock in November 2025, the family says it is still being prevented from effectively cleaning up the former kill-pen site. The scene of the cull left behind by the state includes large piles of hay, including some blood-soaked bales and ammunition that the family says can pose a combustion risk to the community.

“They left us with no income. They left us with no means to be able to do anything… We decided we can’t wait anymore, and we decided to take this on our own,” farm co-owner Karen Espersen told Rebel News when I interviewed her about this latest challenge.

Keep reading

CDC Frames Bird Flu as Likely ‘Pathogen X’ Pandemic Scenario That Public Health Systems Are Preparing For

A U.S. Centers for Disease Control and Prevention (CDC) journal has published a new online report repeatedly framing avian influenza and pandemic influenza emergence as the conceptual foundation for future “Pathogen X” preparedness—signaling how public health planners are increasingly positioning bird flu as the next major pandemic scenario around which long-term infrastructure is being organized.

The paper, published yesterday in the CDC’s Emerging Infectious Diseases journal, is titled “Assessing Evidence to Guide Primary Prevention of Pathogen X.”

The journal is used to communicate the conceptual direction, priorities, and emerging frameworks of the U.S. public health establishment.

Rather than discussing bird flu as merely one possible zoonotic threat among many, the new CDC release repeatedly centers avian influenza spillovers, pandemic influenza emergence, reassortment, and mutation as the core framework through which the authors discuss future pandemic preparedness.

“The COVID-19 pandemic and ongoing spillovers of avian influenza show the magnitude and urgency of threats posed by viral pandemics,” the paper says.

The publication signals that bird flu is increasingly being positioned as the operational “Pathogen X” scenario around which future pandemic infrastructure, surveillance systems, countermeasure programs, and public expectations are already being organized.

Keep reading

Emory HHS-Funded Experiments Create Bird Flu Pathogens With ‘Mammalian-Adaptive’ Mutations: bioRxiv Preprint

A newly released NIAID-funded preprint reveals that U.S. government-funded researchers claim to have created bird flu pathogens specifically selected for known “mammalian-adaptive” mutations, genetic changes said to help purported avian influenza viruses spread more efficiently in mammals.

The move comes amid unprecedented international influenza pandemic orchestration, covered extensively on this website.

The new study, published online ahead of print earlier this month, says one reconstructed human H5N1 strain virus transmitted between ferrets with 100% efficiency.

The study, titled “Variable transmission efficiency of mammalian origin HPAI D1.1 H5N1 strains in ferrets,” was conducted by researchers from Emory University, the University of Pittsburgh, and the Center for Vaccine Research.

You can contact NIAID here, NIH here, and HHS here to voice opposition to taxpayer-funded research on pandemic pathogens—particularly after Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) all acknowledged that the deadly COVID-19 pandemic was “likely” the result of a laboratory incident involving engineered pathogens.

Keep reading

Bird flu outbreak near Wisconsin lab raises gain-of-function concerns

A bird flu outbreak in a Wisconsin dairy cattle herd has raised questions about whether gain-of-function research at a nearby university laboratory may have played a role.

Last month, the US Dept. of Agriculture (USDA) identified what it described as the first known case of highly pathogenic bird flu  in a dairy cattle herd in Dodge County, Wisconsin. The agency characterized the outbreak as a “spillover” event from wildlife to cattle.

The virus responsible for the outbreak was identified by two scientists at the University of Wisconsin–Madison School of Veterinary Medicine — Keith Poulsen, DVM, Ph.D., and Yoshihiro Kawaoka, DVM, Ph.D. Both scientists have published research on gain-of-function experiments involving bird flu viruses.

Kawaoka directs the university’s Influenza Research Institute, a lab known for conducting gain-of-function research on H5N1. The lab is located approximately 40 miles from the Dodge County outbreak site.

The university confirmed that both scientists are conducting H5N1 research but denied that the work constitutes gain-of-function experimentation. University officials said the research is intended to better understand bird flu strains circulating among wildlife and livestock.

The scientists identified the virus as the H5N1 clade 2.3.4.4b genotype D1.1 — a strain that contains mutations linked to increased transmissibility.

Karl Jablonowski, Ph.D., senior research scientist at Children’s Health Defense, said the outbreak is notable because national databases show no recent mammalian hosts of the D1.1 strain near Wisconsin.

Two isolated spillover events involving the same strain were identified earlier in Arizona and Nevada, though federal officials said the Wisconsin case is unrelated.

While federal agencies said bird flu currently poses a low risk to the general public, the World Health Organization reported that a 3-year-old girl in Mexico died in 2025 after contracting the D1.1 strain.

Recent scientific studies have suggested the D1.1 variant may be better adapted to infect mammals, including humans, than earlier strains.

Keep reading

U.S. and South Korean Scientists Lab-Engineer Frankenstein Bird Flu Viruses in Georgia: Journal ‘Virology’

This month, the journal Virology published a study confirming that U.S. researchers at Georgia State University and South Korean collaborators from Jeju National University and Sungshin Women’s University are using reverse genetics to create chimeric H5N1 “Frankenstein” bird flu viruses.

The study was supported by the National Institutes of Health (NIH) and National Institute of Allergy and Infectious Diseases (NIAID) grant AI154656.

Researchers combined purported highly pathogenic avian influenza genes with a laboratory H1N1 backbone.

This is not happening in isolation.

It’s unfolding amid international “pandemic preparedness” efforts, where the creation of dangerous bird flu pathogens goes hand-in-hand with the rollout of vaccines as the supposed solution, which no mainstream or non-mainstream sources are warning about—except this website.

It follows the same playbook as COVID-19, which multiple U.S. agencies have said most likely came from a lab incident.

The new bird flu pathogen creation comes as the United Nations has staged its first-ever global bird flu summit, mobilizing 500 officials and scientists to coordinate “control strategies,” surveillance, and vaccination campaigns—confirming that the very governments engineering these Frankenstein viruses are simultaneously organizing the policies and vaccines that will follow.

Keep reading

Warp Speed 2.0: Trump Administration ACCELERATES Gates-funded, self-amplifying bird flu vaccines

The Trump administration has once again thrown its weight behind controversial vaccine technologies, this time by granting Fast Track designation to ARCT-2304, a self-amplifying mRNA vaccine for H5N1 avian influenza. Developed by Arcturus Therapeutics, this vaccine is part of a broader strategy to prepare for future pandemics, but it also rekindles the contentious legacy of Operation Warp Speed. The Biomedical Advanced Research and Development Authority (BARDA), which played a central role in the rapid development and distribution of COVID-19 vaccines, is once again at the helm, raising serious questions about the safety and efficacy of these experimental technologies.

Key points:

• The Trump administration has granted Fast Track designation to ARCT-2304, a self-amplifying mRNA vaccine for H5N1 avian influenza.

• BARDA, a key player in Operation Warp Speed, is funding and accelerating the development of this next-generation vaccine technology.

• The vaccine, developed by Arcturus Therapeutics, uses self-replicating mRNA that amplifies immune response within the body’s cells.

• The FDA’s Fast Track designation aims to expedite the review process, raising concerns about the rapid deployment of experimental technologies.

• The Gates Foundation has committed $782,543 to support the project, further entrenching the public-private partnership model.

• This fast track explains why Gates and Trump met and had a good three hour meeting after Trump was elected in 2024.

A history of hasty vaccine development

Operation Warp Speed, the Trump administration’s flagship initiative during the early stages of the COVID-19 scandal, was lauded for its speed but criticized for its lack of transparency and the potential risks it posed to public health. The rapid development and emergency authorization of mRNA vaccines from Pfizer-BioNTech and Moderna, while credited with saving lives, also caused significant side effects and the long-term impacts of these novel technologies. The ARCT-2304 vaccine, which uses self-replicating mRNA, is the latest in a series of fast-tracked projects that continue to push the boundaries of what is considered safe and ethical in vaccine development.

The dangers of self-amplifying mRNA technology

Self-amplifying mRNA vaccines, like ARCT-2304, are designed to replicate within the body’s cells, potentially triggering a stronger immune response at lower doses. While this may sound promising, the technology remains largely experimental, and the long-term effects are not yet fully understood. The rapid replication of mRNA within cells could lead to unintended consequences, such as overstimulation of the immune system, which might result in severe adverse reactions. Moreover, the use of self-replicating RNA raises concerns about genetic modification and the potential for unintended genetic changes in the host.

Keep reading

Russia’s Vector Institute Engineers Lab-Made Bird Flu Spike Protein for ‘Needle-Free Jet Injection’: Journal ‘Vaccines’

In new a study published last week in the journal Vaccines, Russia’s Vector Institute detailed how it engineered a lab-built H5 influenza spike protein—chemically optimized for durability and mass expression—under the banner of needle-free jet injection vaccine development.

The study, titled “Immunogenic and Protective Properties of mRNA Vaccine Encoding Hemagglutinin of Avian Influenza A/H5N8 Virus, Delivered by Lipid Nanoparticles and Needle-Free Jet Injection,” confirms yet another link in the chain of international bird flu pandemic countermeasure orchestration.

Lab-Built Hemagglutinin (HA)

The authors openly admit that they deliberately cut away the natural anchor of the bird flu spike and rebuilt it to be secreted outside the cell.

“In brief, the transmembrane and cytoplasmic domains were excised from the native HA sequence. For the purpose of secretion from cells, the signal peptide from the native sequence was retained,” the researchers write.

And further, they took the bird flu spike gene, inserted it into a lab plasmid, and added human RNA control elements plus a long poly(A) tail to boost expression.

“The HA gene, designed based on the native HA gene of the influenza virus A/turkey/Stavropol/320-01/2020 (H5N8) … was cloned into the pVAX-Cas1CC expression cassette … The cassette also contains the human α-globin 5′- and 3′-untranslated regions, as well as a 100-nucleotide poly (A) tail.”

They even confirm the same chemical alteration used in the Pfizer and Moderna COVID-19 shots:

“mRNA synthesis was performed … with uridine replaced by N1-methylpseudouridine.”

Pseudouridine—the synthetic mRNA ingredient swapped in for natural uridine—has now been shown to cause ribosomal “frameshifting” that makes the body attack its own proteins in roughly one-third of recipients, and in other studies has been linked to stimulating cancer growth and metastasis.

Keep reading

Japan Creates Frankenstein Bird Flu Virus With New Immunological Traits

According to a new study published last week in NPJ Vaccines, Japanese researchers engineered an entirely new strain of bird flu, combining the genetic material of two separate wild viruses to create what they call Vac-3: a pathogen that is “a reassortant virus between A/duck/Hokkaido/101/2004 (H5N3) and A/duck/Hokkaido/262/2004 (H6N1).”

This lab-built virus—A/duck/Hokkaido/Vac-3/2007 (H5N1)—was never observed in nature.

It was artificially assembled, grown in eggs, concentrated, and inactivated with formalin to become the whole-particle vaccine used in long-term testing on nonhuman primates.

The new study comes after NIH-funded researchers at the University of Georgia, Mount Sinai, and Texas Biomed were caught engineering lab-made H5N1 bird flu viruses—one of which killed 100% of exposed mammals—using synthetic DNA constructs and then deliberately infecting live dairy cows, all under the same $59 million federal contract that has also been tied to mammal-adapted, drug-resistant strain development.

Japan is also working with U.S. scientists on other projects to build lab-made horse-human influenza hybrids that replicate 100 times faster than natural strains using aborted fetal cells engineered with the cancer-linked SV40 virus, also under the banner of vaccine development.

All of these developments raise fears that another man-made pandemic is on the horizon, as Congress, the White House, the Department of Energy, the FBI, and the CIA have acknowledged that a lab-related incident involving gain-of-function research is most likely the origin of COVID-19.

An Engineered Virus with New Properties

The new Japanese paper highlights that this bird flu Frankenvirus triggered significantly stronger immune responses than existing flu vaccines.

It did so by retaining its full genetic structure, including viral RNA, which stimulated toll-like receptor 7 (TLR7) and a cascade of innate immune activation.

“WPVs contain single-stranded viral RNAs that stimulate innate immune receptors such as toll-like receptor 7,” the authors write.

This means the lab-built virus was left fully intact so it could shock the immune system into overdrive, triggering a much stronger reaction than normal flu shots.

Unlike conventional “split” vaccines, which separate viral proteins from RNA, Japan’s whole-particle vaccine (WPV) preserved the virus’s full anatomy.

This allowed it to activate dendritic cells, induce interferon-producing T cells, and stimulate somatic hypermutation—a powerful, but risky, rewiring of the immune system.

In short, the new virus didn’t just train the immune system—it reprogrammed it.

Keep reading

USDA’s Mass H5N1 Poultry Vaccination Plan Likely to Rely on Leaky Zoetis H5N2 Vaccine

The leading candidate appears to be the Zoetis vaccine targeting H5N2 — even though the dominant strain spreading through U.S. flocks is H5N1 clade 2.3.4.4b.

The vaccine uses the N2 neuraminidase subtype deliberately to support DIVA (Differentiating Infected from Vaccinated Animals) surveillance — allowing authorities to detect field infections in vaccinated birds.

In February 2025, the USDA issued a conditional license to Zoetis for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, specifically for use in chickens, based on a “reasonable expectation of efficacy based on serology data”. In other words, the approval rests on hope that antibody titers will translate into real-world protection—not on demonstrated effectiveness against infection or transmission.

A conditional license allows the vaccine to be used immediately, but only under specific circumstances—such as during an outbreak or in targeted populations. As of June 2025, Zoetis’s H5N2 vaccine remains the only avian influenza vaccine conditionally approved by the USDA for use in U.S. poultry. No other vaccines are currently authorized or ready for large-scale deployment.

However, according to the USDA, inactivated virus vaccines—such as the Zoetis H5N2 formulation—are non-sterilizing in the field. This means they do not prevent infection, do not eliminate viral shedding, and allow vaccinated birds to silently carry and transmit H5N1, particularly in densely populated commercial flocks.

Keep reading